Department of Nephrology, Nanjing Children's Hospital, Affiliated to Nanjing Medical University , Nanjing, Jiangsu Province , China.
Ren Fail. 2014 Apr;36(3):466-72. doi: 10.3109/0886022X.2013.868318. Epub 2013 Dec 17.
The association between angiotensinogen (AGT) M235T gene polymorphism and IgA nephropathy (IgAN) risk remains elusive. Our aim was to evaluate the association between AGT M235T gene polymorphism and IgAN susceptibility by performing a meta-analysis. Eligible studies were searched according to predefined criteria using electronic databases. Eight studies were identified for the analysis of the association between AGT M235T gene polymorphism and IgAN risk. M allele/MM genotype were not associated with IgAN risk in overall populations, Caucasians and Asians (overall populations: p = 0.448 and 0.861, Caucasians: p = 0.618 and 0.886, Asians: p = 0.566 and 0.652). TT/MT genotype were not associated with IgAN risk in overall populations, Caucasians and Asians (overall populations: p = 0.703 and 0.454, Caucasians: p = 0.975 and 0.946, Asians: p = 0.697 and 0.353). No evidence of publication bias was observed. In conclusion, AGT M235T gene polymorphism may not be correlated with IgAN susceptibility in overall populations, Caucasians and Asians. However, more studies should be performed in the future.
血管紧张素原 (AGT) M235T 基因多态性与 IgA 肾病 (IgAN) 风险之间的关联仍不清楚。我们的目的是通过荟萃分析评估 AGT M235T 基因多态性与 IgAN 易感性之间的关系。根据预先设定的标准,使用电子数据库搜索符合条件的研究。确定了八项研究来分析 AGT M235T 基因多态性与 IgAN 风险之间的关系。在总体人群、白人和亚洲人中,M 等位基因/MM 基因型与 IgAN 风险无关(总体人群:p=0.448 和 0.861,白种人:p=0.618 和 0.886,亚洲人:p=0.566 和 0.652)。TT/MT 基因型与总体人群、白人和亚洲人中的 IgAN 风险无关(总体人群:p=0.703 和 0.454,白种人:p=0.975 和 0.946,亚洲人:p=0.697 和 0.353)。未观察到发表偏倚的证据。总之,AGT M235T 基因多态性与总体人群、白人和亚洲人中的 IgAN 易感性可能无关。然而,未来应该进行更多的研究。